Form 8-K - Current report:
SEC Accession No. 0001193125-25-002550
Filing Date
2025-01-07
Accepted
2025-01-07 07:06:01
Documents
44
Period of Report
2025-01-07
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d915192d8k.htm   iXBRL 8-K 35620
2 EX-99.1 d915192dex991.htm EX-99.1 20798
3 EX-99.2 d915192dex992.htm EX-99.2 33341
7 GRAPHIC g915192ex99_2s10g1.jpg GRAPHIC 87149
8 GRAPHIC g915192ex99_2s11g1.jpg GRAPHIC 82293
9 GRAPHIC g915192ex99_2s12g1.jpg GRAPHIC 92906
10 GRAPHIC g915192ex99_2s13g1.jpg GRAPHIC 98039
11 GRAPHIC g915192ex99_2s14g1.jpg GRAPHIC 104980
12 GRAPHIC g915192ex99_2s15g1.jpg GRAPHIC 94872
13 GRAPHIC g915192ex99_2s16g1.jpg GRAPHIC 98393
14 GRAPHIC g915192ex99_2s17g1.jpg GRAPHIC 142145
15 GRAPHIC g915192ex99_2s18g1.jpg GRAPHIC 100291
16 GRAPHIC g915192ex99_2s19g1.jpg GRAPHIC 63302
17 GRAPHIC g915192ex99_2s1g1.jpg GRAPHIC 88790
18 GRAPHIC g915192ex99_2s20g1.jpg GRAPHIC 102085
19 GRAPHIC g915192ex99_2s21g1.jpg GRAPHIC 86681
20 GRAPHIC g915192ex99_2s22g1.jpg GRAPHIC 98282
21 GRAPHIC g915192ex99_2s23g1.jpg GRAPHIC 123664
22 GRAPHIC g915192ex99_2s24g1.jpg GRAPHIC 100013
23 GRAPHIC g915192ex99_2s25g1.jpg GRAPHIC 108589
24 GRAPHIC g915192ex99_2s26g1.jpg GRAPHIC 74386
25 GRAPHIC g915192ex99_2s27g1.jpg GRAPHIC 93332
26 GRAPHIC g915192ex99_2s28g1.jpg GRAPHIC 97742
27 GRAPHIC g915192ex99_2s29g1.jpg GRAPHIC 68773
28 GRAPHIC g915192ex99_2s2g1.jpg GRAPHIC 65367
29 GRAPHIC g915192ex99_2s3g1.jpg GRAPHIC 201943
30 GRAPHIC g915192ex99_2s4g1.jpg GRAPHIC 98007
31 GRAPHIC g915192ex99_2s5g1.jpg GRAPHIC 114855
32 GRAPHIC g915192ex99_2s6g1.jpg GRAPHIC 103041
33 GRAPHIC g915192ex99_2s7g1.jpg GRAPHIC 96215
34 GRAPHIC g915192ex99_2s8g1.jpg GRAPHIC 99467
35 GRAPHIC g915192ex99_2s9g1.jpg GRAPHIC 80731
  Complete submission text file 0001193125-25-002550.txt   4183729

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA stok-20250107.xsd EX-101.SCH 2880
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE stok-20250107_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stok-20250107_pre.xml EX-101.PRE 10832
46 EXTRACTED XBRL INSTANCE DOCUMENT d915192d8k_htm.xml XML 3497
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38938 | Film No.: 25513461
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)